ライフサイエンスコーパス: lithium carbonate

1 trolled treatment study of sustained-release lithium carbonate.

2 sychotic haloperidol and the mood stabilizer lithium carbonate.

3 Lithium carbonate, a drug for the treatment of bipolar d

4 ensus values of -46.6 per thousand to L-SVEC lithium carbonate and +1.95 per thousand to NBS 19 calci

5 yroid surgery and irradiation, drugs such as lithium carbonate and amiodarone, and pituitary and hypo

6 rs compared the tolerability and efficacy of lithium carbonate and divalproex in 224 inpatients and o

7 jects received treatment as usual, including lithium carbonate and psychosocial interventions, and we

8 Lithium carbonate and valproate semisodium are both reco

9 tion pathways in a manner similar to that of lithium carbonate and valproate, 2 effective treatments

10 rature of synthesis, lower concentrations of lithium carbonate, and higher current density promotes C

11 methanol vs ethanol)- and base (potassium vs lithium carbonate)-assisted switchable synthesis of satu

12 tions of 50 wt% sodium carbonate relative to lithium carbonate at an electrolysis temperature of 670

13 were randomized to receive extended-release lithium carbonate beginning at 600 mg/d or placebo.

14 ntly improved while taking sustained-release lithium carbonate compared to placebo on total pathologi

15 in the group treated with sustained-release lithium carbonate compared to placebo.

16 dition of 5-10 wt% lithium metaborate to the lithium carbonate electrolyte boron dopes the CNTs incre

17 In a pure molten lithium carbonate electrolyte, thicker walled CNTs (100-

18 The authors examined the efficacy of lithium carbonate for treating conduct disorder in adole

19 no agreed on treatment for such aggression, lithium carbonate has shown promise in some studies invo

20 QOC study and in a second clinical study of lithium carbonate in ALS.

21 The role of residual lithium carbonate in the electrochemistry and outgassing

22 pment in ALS, with a confirmatory trial with lithium carbonate in UNC13A cases now underway and futur

23 d the accessibility of this Li compared with lithium carbonate (Li(2)CO(3)), often used as psychiatri

24 ation, we show that the presence of residual lithium carbonate (Li2CO3) on the surface of both Ni-ric

25 orrected (13)C/(12)C ratios for NIST RM8545 (Lithium Carbonate LSVEC), NIST RM8573 (L-Glutamic Acid U

26 ion of the VPDB scale, a second fixed point (lithium carbonate, LSVEC) was introduced in 2006 [T.

27 polar I or II disorder patients treated with lithium carbonate or citrate in a second cohort from the

28 rder, including 458 individuals treated with lithium carbonate or citrate, who were participants in t

29 paroxetine, up to 50 mg daily, augmented by lithium carbonate or desipramine hydrochloride if necess

30 itable fMRI data) received 11 (+/-1) days of lithium carbonate or placebo intervention (double-blind)

31 suitable fMRI data) received 11 ( 1) days of lithium carbonate or placebo intervention (double-blind)

32 ere randomized to receive divalproex sodium, lithium carbonate, or placebo (ratio, 2:1:2).

33 d not undergo colectomy will be treated with lithium carbonate orally achieving a serum level of 0.2-

34 rn (IRR), and payback period (PBP) across 21 lithium carbonate price scenarios ($10,000 to $50,000/to

35 he addition of 7.7 wt% calcium metaborate to lithium carbonate, produces unusually thin walled CNTs u

36 he addition of calcium carbonate to a molten lithium carbonate supports the electrosynthesis of thinn

37 With lithium carbonate, the orthorhombic perovskite o-YMnO(3)

38 rum disorders; it compares sustained-release lithium carbonate to placebo.

39 ateral sclerosis (ALS) who experimented with lithium carbonate treatment.

40 an other bipolar patients, particularly when lithium carbonate was being used without tricyclic antid